1-6 of 6
Paul Evans, Phd
Close
Sort by
Journal Articles

BCR Unresponsiveness and 13q14 Duplication Underpin Spontaneous Disease Regression in Chronic Lymphocytic Leukemia

Marwan Kwok, MBBS,MRCP, Andy Rawstron, PhD, Angelo Agathanggelou, PhD, Anshita Goel, PhD, Ceri Oldreive, PhD, Rhiannon E Jones, PhD, Samantha Drennan, PhD, Archana Sharma-Oates, PhD, Paul Evans, PhD, Edward Smith, MSc, Jingwen Mao, Jamie Beaumont, Jusveen Rai, Mayumi Hamada, MB ChB, Surita Dalal, PhD, Naheema Gordon, MSc, Nicholas Davies, PhD, Helen Parry, MB ChB, MRCP, PhD, Andrew Beggs, MBBS, PhD FRCS, Talha Munir, Paul Moreton, MD MRCP, FRCPath, Shankara Paneesha, MD MRCP, FRCPath, Guy Pratt, MD FRCP, FRCPath, Malcolm Taylor, PhD, Francesco Forconi, MD DM, PhD FRCPath, Duncan M Baird, PhD, Jean-Baptiste Cazier, PhD, Paul Moss, MBBS, PhD FRCP, Peter Hillmen, MBChB, PhD, Tatjana Stankovic, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3004.
https://doi.org/10.1182/blood.V130.Suppl_1.3004.3004
Published: 2017
Journal Articles

Mutational Profiling of Peripheral Blood and Bone Marrow Samples Discriminates Reactive Monocytosis from Chronic Myelomonocytic Leukaemia

Catherine Cargo, MB, FRCPath, Matt Cullen, PhD, Jan Taylor, PhD, Mike Short, BSc, Paul Evans, PhD, Simon Crouch, PhD
Journal: Blood
Blood (2016) 128 (22): 3181.
https://doi.org/10.1182/blood.V128.22.3181.3181
Published: 2016
Journal Articles

Early Diagnosis of Myelodysplastic Syndromes Can be Improved By Deep Sequencing and Array Based Cytogenetics

Catherine Cargo, MB FRCPath, Nicola Rowbotham, PhD, Paul Evans, PhD, Sharon Barrans, PhD, Simon Crouch, PhD, Andrew Jack, PhD
Journal: Blood
Blood (2014) 124 (21): 167.
https://doi.org/10.1182/blood.V124.21.167.167
Published: 2014
Journal Articles

Levels of Phosphorylated P70 S6 Kinase and Phosphorylated ERK1&2 Predict Overall Survival and Time to First Treatment In Chronic Lymphocytic Leukaemia

James R Bailey, MD, PhD, Gina L Eagle, PhD, Pointon Jo, Ria Brathwaite, Abbott Jody, Russell Patmore, MD, Paul Evans, PhD, John Greenman, PhD, Lynn Cawkwell, PhD, David J Allsup, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1363.
https://doi.org/10.1182/blood.V116.21.1363.1363
Published: 2010
Journal Articles

Final Report of the UKCLL02 Trial: A Phase II Study of Subcutaneous Alemtuzumab Plus Fludarabine in Patients with Fludarabine Refractory CLL (on Behalf of the NCRI CLL Trials Sub-Group).

Hazem A. Sayala, MD, Paul Moreton, MD, Richard A. Jones, PhD, Andy C. Rawstron, PhD, Sheila J. O’Connor, PhD, Paul Evans, PhD, Carter Anthony, MsC, Claire Dearden, MD, Estella Matutes, MD, PhD, Andrew R. Pettitt, MD, PhD, Daniel B. Kennedy, MD, Peter Hillmen, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 34.
https://doi.org/10.1182/blood.V108.11.34.34
Published: 2006
Journal Articles

Ig Sequence Analysis in Waldenstrom’s Macroglobulinemia and IgM MGUS.

Rebecca A. Rollett, BSc, Elizabeth Wilkinson, MSc, David Gonzalez, Phd, James A.L. Fenton, Phd, Michael Short, BSc, Paul Evans, Phd, Roger G. Owen, MD
Journal: Blood
Blood (2004) 104 (11): 3653.
https://doi.org/10.1182/blood.V104.11.3653.3653
Published: 2004